MatsukiyoCocokara & Co. (TYO:3088)
Japan
· Delayed Price · Currency is JPY 2,894.00
+214.00 (7.99%)
May 13, 2025, 9:45 AM JST
MatsukiyoCocokara & Co. Revenue
In the fiscal year ending March 31, 2025, MatsukiyoCocokara & Co. had annual revenue of 1.06T JPY with 3.82% growth. MatsukiyoCocokara & Co. had revenue of 260.11B in the quarter ending March 31, 2025, with 3.14% growth.
Revenue
1,061.63B
Revenue Growth
+3.82%
P/S Ratio
1.13
Revenue / Employee
79.40M
Employees
13,371
Market Cap
1,200.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,061.63B | 39.10B | 3.82% |
| Mar 31, 2024 | 1,022.53B | 71.28B | 7.49% |
| Mar 31, 2023 | 951.25B | 221.28B | 30.31% |
| Mar 31, 2022 | 729.97B | 173.06B | 31.08% |
| Mar 31, 2021 | 556.91B | -33.69B | -5.70% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |